dc.contributor.author | Selenius, Jannica S. | |
dc.contributor.author | Silveira, Patricia P. | |
dc.contributor.author | Salonen, Minna | |
dc.contributor.author | Kautiainen, Hannu | |
dc.contributor.author | von Bonsdorff, Mikaela | |
dc.contributor.author | Kajantie, Eero | |
dc.contributor.author | Lahti, Jari | |
dc.contributor.author | Eriksson, Johan G. | |
dc.contributor.author | Wasenius, Niko S. | |
dc.date.accessioned | 2021-12-02T10:43:41Z | |
dc.date.available | 2021-12-02T10:43:41Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Selenius, J. S., Silveira, P. P., Salonen, M., Kautiainen, H., von Bonsdorff, M., Kajantie, E., Lahti, J., Eriksson, J. G., & Wasenius, N. S. (2021). The relationship between health-related quality of life and melancholic depressive symptoms is modified by brain insulin receptor gene network. <i>Scientific Reports</i>, <i>11</i>, Article 21588. <a href="https://doi.org/10.1038/s41598-021-00631-w" target="_blank">https://doi.org/10.1038/s41598-021-00631-w</a> | |
dc.identifier.other | CONVID_102303302 | |
dc.identifier.uri | https://jyx.jyu.fi/handle/123456789/78871 | |
dc.description.abstract | To investigate whether expression-based polygenic risk scores for the insulin receptor gene network (ePRS-IRs) modifiy the association between type of depressive symptoms and health-related quality of life (HRQoL). This cross-sectional study includes 1558 individuals from the Helsinki Birth Cohort Study. Between 2001 and 2004, the Short Form-36 questionnaire was employed to assess mental and physical components of HRQoL and Beck Depression Inventory (BDI) to assess depressive symptoms. Depressive symptoms were categorized into minimal (BDI < 10), non-melancholic and melancholic types of depression. The ePRS-IRs were calculated for the hippocampal (hePRS-IR) and the mesocorticolimbic (mePRS-IR) regions of the brain. General linear regression models adjusted for age, sex, population stratification, lifestyle factors and body mass index were applied to analyze the data. Both types of depressive symptoms were associated with lower HRQoL (p < 0.0001). HePRS-IR modified the association between the types of depression and mental HRQoL (p for interaction = 0.005). Melancholic type of depressive symptoms was associated with higher mental HRQoL compared to the non-melancholic symptoms among individuals with low hePRS-IR (adjusted mean 4.1, 95% CI 0.7–7.4, p = 0.018). However, no such difference was evident in moderate or high hePRS-IR groups as higher hePRS-IR was associated with lower mental HRQoL (B = − 3.4, 95% CI − 5.6 to − 1.2) in individuals with melancholic type of depressive symptoms. No direct associations were detected between the ePRS-IRs and type of depressive symptoms or HRQoL. Variations in the glucose-insulin metabolism can lower HRQoL in individuals with melancholic depressive symptoms. | en |
dc.format.mimetype | application/pdf | |
dc.language.iso | eng | |
dc.publisher | Nature Publishing Group | |
dc.relation.ispartofseries | Scientific Reports | |
dc.rights | CC BY 4.0 | |
dc.title | The relationship between health-related quality of life and melancholic depressive symptoms is modified by brain insulin receptor gene network | |
dc.type | article | |
dc.identifier.urn | URN:NBN:fi:jyu-202112025869 | |
dc.contributor.laitos | Liikuntatieteellinen tiedekunta | fi |
dc.contributor.laitos | Faculty of Sport and Health Sciences | en |
dc.contributor.oppiaine | Gerontologia ja kansanterveys | fi |
dc.contributor.oppiaine | Gerontologian tutkimuskeskus | fi |
dc.contributor.oppiaine | Hyvinvoinnin tutkimuksen yhteisö | fi |
dc.contributor.oppiaine | Gerontology and Public Health | en |
dc.contributor.oppiaine | Gerontology Research Center | en |
dc.contributor.oppiaine | School of Wellbeing | en |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | |
dc.type.coar | http://purl.org/coar/resource_type/c_2df8fbb1 | |
dc.description.reviewstatus | peerReviewed | |
dc.relation.issn | 2045-2322 | |
dc.relation.volume | 11 | |
dc.type.version | publishedVersion | |
dc.rights.copyright | © The Author(s) 2021 | |
dc.rights.accesslevel | openAccess | fi |
dc.subject.yso | riskitekijät | |
dc.subject.yso | geneettiset tekijät | |
dc.subject.yso | glukoosiaineenvaihdunta | |
dc.subject.yso | diabetes | |
dc.subject.yso | elämänlaatu | |
dc.subject.yso | masennus | |
dc.subject.yso | terveydentila | |
dc.format.content | fulltext | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p13277 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p21661 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p39093 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p8304 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p10759 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p7995 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p11646 | |
dc.rights.url | https://creativecommons.org/licenses/by/4.0/ | |
dc.relation.doi | 10.1038/s41598-021-00631-w | |
jyx.fundinginformation | The authors would like to express their gratitude to the participants in the Helsinki Birth Cohort Study. Also special thanks for the funding of the HBCS to the Finnish Foundation for Cardiovascular Research, Finnish Foundation for Diabetes Research, Juho Vainio Foundation, Academy of Finland, Novo Nordisk Foundation, Signe and Ane Gyllenberg Foundation, Samfundet Folkhälsan, Finska Läkaresällskapet, Liv och Hälsa, European Commission FP7 (DORIAN) Grant Agreement No. 278603 and EU H2020-PHC-2014-DynaHealth Grant No. 633595 and EU Horizon 2020 Award 733206 LIFECYCLE. Silveira PP is supported by Canadian Institutes of Health Research (CIHR, PJT-166066, PI Silveira PP). | |
dc.type.okm | A1 | |